- Code Status Decisions for End-Stage Cancer
- Cancer Incidence and Mortality With Aspirin in Older Adults
- Concerns About Methods and Reporting in Proton Craniospinal Irradiation Trial—Reply
- Concerns About Methods and Reporting in Proton Craniospinal Irradiation Trial
- SGLT2 Inhibitors for Patients With Prostate Cancer Undergoing Hormone Therapy
- Cost-Effectiveness of Adjuvant Immunotherapy in Cancer Treatments
- Lullaby for a Dying Self
- Projected Cancer Screening Under the 2025 Medicaid Eligibility Restrictions
- Make Every Cancer Case Count
- Clonal Hematopoiesis and Cardiovascular Disease Risk After Cancer Therapy in Patients With Solid Tumors
- A Woman With Hypermetabolic Lesions in a Leopardlike Pattern
- Errors in Results, Figure 2 Legend, and Table 3
- Lymph Node Dissection Guidelines and Survival in Lung Adenocarcinoma
- A Completely Unfair Time of Ultimate Suffering
- Ocular Toxic Effects During Mirvetuximab Soravtansine Therapy
